Previous 10 | Next 10 |
2023-06-22 16:37:26 ET Summary In November 2020, I rated Surmodics as "one for the future". The "future" has arrived, and there are now several catalysts driving SRDX's prospects higher, discussed in detail in this report. Based on the latest investment findings, I reiterate t...
Surmodics to receive $27 million milestone payment from Abbott Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced the receipt of U.S. Food and Drug Administration (FDA) approval for the Su...
Addition to Pounce ™ thrombectomy platform with the low-profile (LP) model will allow for efficient clot removal in below-the-knee peripheral arteries (2 mm to 4 mm), expanding the addressable market for the Pounce ™ platform Surmodics, Inc. (Nasdaq: SRDX), a leadi...
2023-06-13 13:11:25 ET Shares of Surmodics (NASDAQ: SRDX) were up 16% early Tuesday afternoon as the healthcare company, which provides chemicals for in vitro diagnostic immunoassay tests and makes coatings for intravascular medical devices, got an upgraded rating from Needham. ...
2023-06-13 10:10:06 ET Gainers: First Wave BioPharma ( FWBI ) +150% . YS Biopharma ( YS ) +20% . Akoya Biosciences ( AKYA ) +17% . Evoke Pharma ( EVOK ) +16% . Surmodics ( SRDX ) +16% . Losers: Jin Medical International ( ...
2023-06-13 08:33:04 ET Surmodics, Inc. ( NASDAQ: SRDX ) added ~4% premarket Tuesday after Needham upgraded the medical device maker to Buy from Hold, citing a faster-than-expected FDA approval for its SurVeil drug-coated balloon (DCB). In January, the FDA declined to approve...
2023-06-07 02:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that management will participate in the Jefferies Healthcare Conference, which is being held in New York, NY, from June 7-9, 2023. Management will ...
2023-05-18 19:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-05-12 17:46:07 ET Surmodics ( NASDAQ: SRDX ) has filed for a $200M mixed shelf securities offering. The filing does not necessarily indicate that a sale has begun or will occur in the future. The company intends to use the proceeds for general corporate purposes. ...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, NY / ACCESSWIRE / July 3, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Surmodics, Inc. (NASDAQ:SRDX)'s sale ...
Access to Premier’s healthcare group purchasing organization (GPO) expected to expand national market reach for Surmodics endovascular thrombectomy solutions. Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies, today announce...
NEW YORK, NY / ACCESSWIRE / June 5, 2024 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Stericycle, Inc. (NASDAQ:SRCL)'s sale...